ERAS vs LEGN: stock comparison and AI forecast
Erasca, Inc. (ERAS) and Legend Biotech Corp (LEGN) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
ERAS Erasca, Inc.
- Price
- $13.27 +27.6% · 6M
- Market Cap
- $4.64B
- P/E Ratio
- –
- Size
- mid-cap
- AI Forecast
LEGN Legend Biotech Corp
- Price
- $22.54 -21.1% · 6M
- Market Cap
- $4.17B
- P/E Ratio
- –
- Size
- mid-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Six-month price performance
Closing prices rebased to 100 at the start of the window.
Key facts
- ERAS is 1.1 times larger than LEGN by market capitalization ($4.64B against $4.17B).
- Over the last six months ERAS returned +27.6% and LEGN -21.1%.
- Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | ERAS | LEGN |
|---|---|---|
| Market Cap | $4.64B | $4.17B |
| P/B Ratio | 12.83x | – |
| EPS | $-0.46 | $-1.53 |
| Book Value/Share | $1.03 | – |
| Revenue/Share | – | $7.30 |
| FCF/Share | $-0.28 | $-2.52 |
Profitability & Margins
| Metric | ERAS | LEGN |
|---|---|---|
| ROIC | -75.4% | – |
| Gross Margin | – | 50.0% |
| EBT Margin | – | -40.4% |
| Tax Rate | – | -3.1% |
Financial Health
| Metric | ERAS | LEGN |
|---|---|---|
| Current Ratio | 8.29x | 1.96x |
| Quick Ratio | – | 1.91x |
| D/E Ratio | 0.20x | – |
| Financial Leverage | 1.20x | – |
| Working Capital | $245M | $611M |
Cash Flow
| Metric | ERAS | LEGN |
|---|---|---|
| Operating Cash Flow | -$98M | -$409M |
| Free Cash Flow | -$98M | -$467M |
| Capital Spending | -$60K | -$58M |
| FCF/Sales | – | -34.6% |
| CapEx/Sales | – | 4.3% |
Operational Efficiency
| Metric | ERAS | LEGN |
|---|---|---|
| Asset Turnover | – | 0.78x |
| Inventory Turnover | – | 21.1x |
| Fixed Assets Turnover | – | 11.6x |
| Days Inventory | – | 17 days |
Income Statement
| Metric | ERAS | LEGN |
|---|---|---|
| Total Revenue | – | $1.35B |
| Operating Income | -$303M | – |
| R&D Expense | $109M | $728M |
| Cost of Goods Sold | – | $675M |
Dividend & Shareholder Information
| Metric | ERAS | LEGN |
|---|---|---|
| Shares Outstanding | 350M | 185M |
ERAS vs LEGN: stock comparison and AI forecast
Which is bigger, ERAS or LEGN?
ERAS is 1.1 times larger than LEGN by market capitalization ($4.64B against $4.17B).
Which stock performed better over the last six months, ERAS or LEGN?
Over the last six months ERAS returned +27.6% and LEGN -21.1%.
Which one does Intratio's AI model rank higher, ERAS or LEGN?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.